NGS 自動化市場規模、佔有率和成長分析（按產品類型、應用、定序類型、最終用戶和地區）- 產業預測，2025-2032

2023 年全球 NGS 自動化市場規模為 40 萬美元，預計將從 2024 年的 45 萬美元成長到 2032 年的 124 萬美元，預測期間（2025-2032 年）的複合年成長率為 13.4%。

下一代定序 (NGS)，也稱為高通量定序，與傳統方法相比，它能夠快速且經濟高效地進行 DNA 和 RNA 分析，從而徹底改變基因組學和分子生物學。透過先進的液體處理設備實現的NGS自動化，可確保資料的一致性和可重複性，同時減少時間和成本，從而提高文庫製備品質。這種自動化過程最大限度地減少了人與樣品的接觸，從而降低了污染的風險。隨著對高效工作流程的需求不斷成長，人們大幅轉向自動化 NGS 流程來提高生產力並減少錯誤。 NGS 市場主要受其在藥物開發中的應用以及主要企業可能會影響整體市場的成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

NGS 自動化市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 工作站/機器人平台
• 試劑和耗材

NGS 自動化市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 藥物研發
• 臨床診斷
• 腫瘤學
• 感染疾病
• 生殖健康
• 其他臨床診斷
• 其他用途

NGS 自動化市場規模（依定序類型和複合年成長率） (2025-2032)

• 市場概況
• 全基因組序列分析
• 全EXOME定序
• 標靶基因測序
• 其他

NGS 自動化市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和診斷實驗室
• 製藥和生物技術公司
• 學術研究所
• 其他最終用戶

NGS 自動化市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Roche Holding AG（Switzerland）
• Danaher Corporation（USA）
• Tecan Group Ltd.（Switzerland）
• Hamilton Company（USA）
• Eppendorf AG（Germany）
• Hudson Robotics（USA）
• 10x Genomics, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Honeywell International Inc.（USA）
• Siemens AG（Germany）
• Abbott Laboratories（USA）
• LabCorp（Laboratory Corporation of America Holdings）（USA）
• Charles River Laboratories International, Inc.（USA）
• Brooks Life Sciences（USA）

結論和建議

Global NGS Automation Market size was valued at USD 0.4 million in 2023 and is poised to grow from USD 0.45 million in 2024 to USD 1.24 million by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as high-throughput sequencing, is revolutionizing genomics and molecular biology by enabling rapid and cost-effective DNA and RNA analysis compared to traditional methods. Automation in NGS, facilitated by advanced liquid handling devices, enhances library preparation quality by ensuring consistent and reproducible data while reducing time and costs. This automation minimizes human interaction with samples, thereby decreasing contamination risks. As the demand for efficient workflows grows, there is a notable shift towards automated NGS processes to boost productivity and reduce errors. The NGS market is primarily driven by its applications in drug development and comprehensive offerings from key industry players, despite challenges such as high product costs and potential recalls impacting overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ngs Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ngs Automation Market Segmental Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ngs Automation Market

The global NGS automation market is primarily driven by heightened investment in healthcare infrastructure, which is essential for facilitating advancements in automated NGS workflows. Factors such as the rising prevalence of cancer, increased research and development expenditure, and escalating healthcare costs further contribute to the market's growth. Additionally, the expanding applications of next-generation sequencing and the formation of corporate partnerships aimed at enhancing library preparation methods are expected to propel the industry forward. As NGS continues to prove its efficacy in comprehensive genome analysis and the identification of novel viral variants, its role in epidemiological studies, especially in distinguishing between COVID-19, influenza, and other viruses, will be crucial. Collectively, these elements are poised to drive significant growth in the NGS automation sector in the coming years.

Restraints in the Global Ngs Automation Market

The growth of the global NGS automation market is expected to be significantly hindered by the substantial costs associated with installing automation workstations. Key challenges include regulatory hurdles and the lack of standardization in diagnostic testing, alongside the requirement for highly skilled personnel to effectively manage automation software. Additionally, various legal and ethical issues related to DNA sequencing, including concerns about identifiability, informed consent, and the potential for stigmatization, pose further barriers. These ethical dilemmas, coupled with cultural sensitivities, ultimately restrict the market's expansion and limit its overall development potential.

Market Trends of the Global Ngs Automation Market

The Global NGS Automation market is witnessing a significant upward trend, fueled by the increasing demand for streamlined and efficient sequencing processes. Automation in NGS library preparation enhances the reliability and reproducibility of data by facilitating better library quality and maximizing yields. It not only boosts productivity and cuts costs but also minimizes the risk of contamination through reduced manual handling of reagents and samples. As researchers increasingly seek high-throughput solutions to cope with growing genomic data, the NGS automation market is set to expand, driven by technological advancements and the need for stringent quality control in genetic studies and diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Workstation/Robotic Platform
• Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Clinical Diagnostics
• Oncology
• Infectious Diseases
• Reproductive Health
• Other Clinical Diagnostics
• Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2025-2032)

• Market Overview
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Genome Sequencing
• Others

Global NGS Automation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Others End Users

Global NGS Automation Market Size & CAGR (2025-2032)

• North America (Product, Application, Sequencing Type, End User)
  • US
  • Canada
• Europe (Product, Application, Sequencing Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Sequencing Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Sequencing Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Sequencing Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hudson Robotics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeywell International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (Laboratory Corporation of America Holdings) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations